1888 PressRelease Home	Sign In	Register	About Us	Sitemap

1888 Press Release | Tocris Bioscience Press Releases

Tocris.com - Tocris Bioscience Company News Section

Tocris Bioscience Information

Adele Sheehan

Tocris House, IO Centre, Moorend Farm Avenue, Avonmouth, Bristol
Phone: +44 (0)117 916 3333
URL: https://www.tocris.com

Tocris Bioscience is a leading supplier of high performance chemicals, peptides and antibodies, with customers in virtually all of the world’s major pharmaceutical companies, universities and research institutes. The Company is committed to making new life science discoveries possible by providing the highest performing and most innovative range of research reagents.

Tocris Bioscience is a leading supplier of high performance biochemicals, peptides and antibodies, with customers in virtually all of the world’s major pharmaceutical companies, universities and research institutes. The Company is committed to making new life science discoveries possible.

Tocris Bioscience Press Release -

Tocris.com

29
APR

Tocris Bioscience First to Launch Novel Light-Sensitive Caged GABA Compound: RuBi-GABA Licensed from Columbia University

This technology will help scientists to better understand the neuronal circuitry of the brain, as well as molecular and cellular mechanisms of disease, and may lead to the development of safer and more effective therapies for epilepsy, depression, and many other conditions.

Bristol, UK and New York, NY - Tocris Bioscience (www.tocris.com) today announced that they have entered into a license agreement with Columbia Univer ...

27 FEB	Tocris Bioscience Signs Exclusive Deal To Supply Anastrozole And Bicalutamide For Cancer Research
	For the first time, preclinical scientists will be able to buy fully licensed, non-formulated anastrozole and bicalutamide as off-the shelf products for use in biological research. Tocris Bioscience (www.tocris.com) announced today the signing of an exclusive deal with AstraZeneca to supply anastrozole and bicalutamide to researc ...

26 FEB	The First Novel Fluorescent Cannabinoid Ligand, Tocrifluor T1117, Available Exclusively From Tocris Bioscience
	Co developed by Tocris and the University of Glasgow, Tocrifluor T1117 is the CB1 antagonist AM 251 labelled with a rhodamine derivative, and is the first fluorescent cannabinoid ligand commercially available. Tocris Bioscience (www.tocris.com) is pleased to announce the launch of Tocrifluor T1117. New research published by Daly et al (2008) has now shown th ...

02 DEC	A Novel Range Of Conotoxins From Tocris To Boost Neurological Research
	Tocris Bioscience today announced the launch of a new range of conotoxins for use in pre-clinical research. Conotoxins, derived from cone snail venoms, are small peptide toxins typically 12-30 amino acid residues in length. As the active components of the v ...